BHST
Bioharvest Sciences Inc
NASDAQ · Consumer products
$4.79
+0.14 (+3.01%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 79.81M | 72.35M | 77.50M |
| Net Income | 9.14M | 7.84M | 7.97M |
| EPS | — | — | — |
| Profit Margin | 11.5% | 10.8% | 10.3% |
| Rev Growth | +14.6% | +12.0% | -2.5% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 71.15M | 71.70M | 68.34M |
| Total Equity | 76.04M | 83.93M | 92.20M |
| D/E Ratio | 0.94 | 0.85 | 0.74 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 10.94M | 9.97M | 9.95M |
| Free Cash Flow | 7.79M | 6.73M | 8.70M |